Sickle Cell Retinopathy
暂无分享,去创建一个
[1] Jennifer I. Lim,et al. Longitudinal Study of Peripapillary Thinning in Sickle Cell Hemoglobinopathies. , 2019, American journal of ophthalmology.
[2] M. Gladwin,et al. Pathophysiology of Sickle Cell Disease. , 2019, Annual review of pathology.
[3] Jennifer I. Lim,et al. Analysis of Retinal Thinning Using Spectral-domain Optical Coherence Tomography Imaging of Sickle Cell Retinopathy Eyes Compared to Age- and Race-Matched Control Eyes. , 2018, American journal of ophthalmology.
[4] M. Cappellini,et al. Sickle cell maculopathy: Identification of systemic risk factors, and microstructural analysis of individual retinal layers of the macula , 2018, PloS one.
[5] Jonathan S. Chang,et al. Optical Coherence Tomography Angiography and Ultra-widefield Fluorescein Angiography for Early Detection of Adolescent Sickle Retinopathy. , 2017, American journal of ophthalmology.
[6] B. Khan,et al. Sickle cell retinopathy: improving care with a multidisciplinary approach , 2017, Journal of multidisciplinary healthcare.
[7] Ian C. Han,et al. Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy , 2017, PloS one.
[8] Jing Jin,et al. Funduscopic examination and SD-OCT in detecting sickle cell retinopathy among pediatric patients. , 2017, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.
[9] Mahnaz Shahidi,et al. Method for quantitative assessment of retinal vessel tortuosity in optical coherence tomography angiography applied to sickle cell retinopathy. , 2017, Biomedical optics express.
[10] Katia D. Pacheco,et al. Evaluation of Macular Vascular Abnormalities Identified by Optical Coherence Tomography Angiography in Sickle Cell Disease. , 2017, American journal of ophthalmology.
[11] Xincheng Yao,et al. Quantitative characteristics of sickle cell retinopathy in optical coherence tomography angiography. , 2017, Biomedical optics express.
[12] G. Semenza,et al. Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy , 2016, Investigative ophthalmology & visual science.
[13] Ian C. Han,et al. CORRELATION OF MULTIMODAL IMAGING IN SICKLE CELL RETINOPATHY , 2016, Retina.
[14] S. Grover,et al. Capillary Nonperfusion by Novel Technology of OCT Angiography in a Patient with Sickle Cell Disease with Normal Fluorescein Angiogram , 2016, European journal of ophthalmology.
[15] E. Souied,et al. Macular Microangiopathy in Sickle Cell Disease Using Optical Coherence Tomography Angiography. , 2016, American journal of ophthalmology.
[16] Ian C. Han,et al. Macular Vascular Abnormalities Identified by Optical Coherence Tomographic Angiography in Patients With Sickle Cell Disease. , 2015, JAMA ophthalmology.
[17] R. Ware,et al. Hydroxyurea therapy for sickle cell anemia , 2015, Expert opinion on drug safety.
[18] A. Ho,et al. Spectrum of Retinal Vascular Diseases Associated With Paracentral Acute Middle Maculopathy. , 2015, American journal of ophthalmology.
[19] Mahnaz Shahidi,et al. Conjunctival microvascular haemodynamics in sickle cell retinopathy , 2015, Acta ophthalmologica.
[20] M. Moschos,et al. Intravitreal Ranibizumab for Stage IV Proliferative Sickle Cell Retinopathy: A First Case Report , 2014, Case reports in ophthalmological medicine.
[21] William J Savage,et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. , 2014, JAMA.
[22] H. Flynn,et al. Vitreoretinal management and surgical outcomes in proliferative sickle retinopathy: a case series. , 2014, American journal of ophthalmology.
[23] P. Rosenthal,et al. Biochemical and immunological mechanisms by which sickle cell trait protects against malaria , 2013, Malaria Journal.
[24] Jennifer I. Lim,et al. Human bulbar conjunctival hemodynamics in hemoglobin SS and SC disease , 2013, American journal of hematology.
[25] Winfred C. Wang,et al. Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children , 2013, British journal of haematology.
[26] Jennifer I. Lim,et al. Peripapillary retinal nerve fiber layer thickness in sickle-cell hemoglobinopathies using spectral-domain optical coherence tomography. , 2013, American journal of ophthalmology.
[27] Jennifer I. Lim. Ophthalmic manifestations of sickle cell disease: update of the latest findings , 2012, Current opinion in ophthalmology.
[28] M. Goldberg,et al. Beyond the Definitions of the Phenotypic Complications of Sickle Cell Disease: An Update on Management , 2012, TheScientificWorldJournal.
[29] Jennifer I. Lim,et al. Central macular splaying and outer retinal thinning in asymptomatic sickle cell patients by spectral-domain optical coherence tomography. , 2011, American journal of ophthalmology.
[30] I. Bechmann,et al. Sickle Hemoglobin Confers Tolerance to Plasmodium Infection , 2011, Cell.
[31] Jennifer I. Lim,et al. Structural and functional correlation in sickle cell retinopathy using spectral-domain optical coherence tomography and scanning laser ophthalmoscope microperimetry. , 2011, American journal of ophthalmology.
[32] S. Kiss,et al. DETECTION AND MONITORING OF SICKLE CELL RETINOPATHY USING ULTRA WIDE-FIELD COLOR PHOTOGRAPHY AND FLUORESCEIN ANGIOGRAPHY , 2011, Retina.
[33] K. Hassell. Population estimates of sickle cell disease in the U.S. , 2010, American journal of preventive medicine.
[34] O. Babalola. Intravitreal bevacizumab (Avastin) associated with secondary hyphaema in a case of proliferative sickle cell retinopathy , 2010, BMJ Case Reports.
[35] Jonathan D. Powell,et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. , 2009, The New England journal of medicine.
[36] T. Williamson,et al. Vitreoretinal management of the complications of sickle cell retinopathy by observation or pars plana vitrectomy , 2009, Eye.
[37] B. Pollock,et al. National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease. , 2008, Annals of internal medicine.
[38] S. Shaikh. Intravitreal bevacizumab (Avastin) for the treatment of proliferative sickle retinopathy , 2008, Indian journal of ophthalmology.
[39] M. Gladwin,et al. Sickle cell disease vasculopathy: a state of nitric oxide resistance. , 2008, Free radical biology & medicine.
[40] H. Gill,et al. A screening strategy for the detection of sickle cell retinopathy in pediatric patients. , 2008, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[41] I. Scott,et al. Intravitreal bevacizumab (Avastin) injection associated with regression of retinal neovascularization caused by sickle cell retinopathy. , 2006, Acta ophthalmologica Scandinavica.
[42] J. Duker,et al. Optical coherence tomography demonstration of macular infarction in sickle cell retinopathy. , 2006, Archives of ophthalmology.
[43] A. Bird,et al. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study. , 2005, Ophthalmology.
[44] K. Eng,et al. Retinopathy in sickle cell trait: does it exist? , 2003, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[45] W. Walton,et al. Management of traumatic hyphema. , 2002, Survey of ophthalmology.
[46] M L Terrin,et al. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study of Hydroxyurea. , 1997, Blood.
[47] J. Meurs. Evolution of a Retinal Hemorrhage in a Patient With Sickle Cell-Hemoglobin C Disease , 1995 .
[48] J. Talbot,et al. New classification of peripheral retinal vascular changes in sickle cell disease. , 1994, The British journal of ophthalmology.
[49] M. Goldberg,et al. A randomized clinical trial of feeder vessel photocoagulation of sickle cell retinopathy. A long-term follow-up. , 1991, Ophthalmology.
[50] L. Jampol,et al. A randomized clinical trial of scatter photocoagulation of proliferative sickle cell retinopathy. , 1991, Archives of ophthalmology.
[51] J. Morris,et al. Risk factors for proliferative sickle retinopathy. , 1990, The British journal of ophthalmology.
[52] M. Goldberg,et al. The evolution of salmon-patch hemorrhages in sickle cell retinopathy. , 1989, Archives of ophthalmology.
[53] T. Savitt,et al. Herrick's 1910 case report of sickle cell anemia. The rest of the story. , 1989, JAMA.
[54] J. Clarkson,et al. Pars plana vitrectomy in the management of complications of proliferative sickle retinopathy. , 1988, Archives of ophthalmology.
[55] L. Jampol,et al. A Randomized Clinical Trial of Feeder Vessel Photocoagulation of Proliferative Sickle Cell Retinonathy: II. Update and Analysis of Risk Factors , 1984 .
[56] L. Jampol,et al. A randomized clinical trial of feeder vessel photocoagulation of proliferative sickle cell retinopathy. I. Preliminary results. , 1983, Ophthalmology.
[57] M. Goldberg,et al. Chorioretinal and choriovitreal neovascularization. Their presence after photocoagulation of proliferative sickle cell retinopathy. , 1981, Archives of ophthalmology.
[58] L. Jampol,et al. Choroidal neovascularisation induced by photocoagulation in sickle cell disease. , 1981, The British journal of ophthalmology.
[59] G. Serjeant,et al. Haematological factors associated with proliferative retinopathy in homozygous sickle cell disease. , 1981, The British journal of ophthalmology.
[60] G. Serjeant,et al. Behaviour of untreated proliferative sickle retinopathy. , 1980, The British journal of ophthalmology.
[61] M. Goldberg,et al. Retinal breaks after photocoagulation of proliferative sickle cell retinopathy. , 1980, Archives of ophthalmology.
[62] M. Goldberg,et al. Choroidal occlusive disease in sickle cell hemoglobinopathies. , 1979, Survey of ophthalmology.
[63] M. Goldbaum,et al. Cryotherapy of proliferative sickle retinopathy, II: triple freeze-thaw cycle. , 1979, The British journal of ophthalmology.
[64] M. Goldbaum,et al. The disc sign in sickling hemoglobinopathies. , 1978, Archives of ophthalmology.
[65] M. Goldbaum,et al. Macular holes associated with proliferative sickle cell retinopathy. , 1978, Archives of ophthalmology.
[66] M. Goldbaum. Retinal depression sign indicating a small retinal infarct. , 1978, American journal of ophthalmology.
[67] M. Goldbaum,et al. Proliferative retinopathy in sickle cell trait. Report of seven cases. , 1977, Archives of internal medicine.
[68] M. Goldbaum,et al. Macular and perimacular vascular remodelling sickling haemoglobinopathies. , 1976, The British journal of ophthalmology.
[69] G. Serjeant,et al. Ocular findings of elderly cases of homozygous sickle-cell disease in Jamaica. , 1976, The British journal of ophthalmology.
[70] M. Goldbaum,et al. Angioid streaks and sickle haemoglobinopathies. , 1976, The British journal of ophthalmology.
[71] M. Goldbaum,et al. Evolution of the retinal black sunburst in sickling haemoglobinopathies. , 1975, The British journal of ophthalmology.
[72] M. Goldberg,et al. Sickling hemoglobinopathies; macular and perimacular vascular abnormalities. , 1974, Archives of ophthalmology.
[73] W. Green,et al. Histopathology of sickle cell retinopathy. , 1973, Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology.
[74] G. Serjeant,et al. Ocular findings in homozygous sickle cell anemia in Jamaica. , 1972, American journal of ophthalmology.
[75] M. Goldberg,et al. Anterior segment ischemia following scleral buckling in sickle cell hemoglobinopathy. , 1971, American journal of ophthalmology.
[76] M. Goldberg. Natural history of untreated proliferative sickle retinopathy. , 1971, Archives of ophthalmology.
[77] M. Goldberg. Classification and pathogenesis of proliferative sickle retinopathy. , 1971, American journal of ophthalmology.
[78] R. Welch,et al. Sickle-cell hemoglobin and its relation to fundus abnormality. , 1966, Archives of ophthalmology.
[79] D. Paton. The conjunctival sign of sickle-cell disease. , 1961, Archives of ophthalmology.
[80] D. Paton. Angioid Streaks and Sickle Cell Anemia: A Report of Two Cases , 1959 .
[81] C. Cope,et al. Intraocular lesions associated with sickle-cell disease. , 1957, A.M.A. archives of ophthalmology.
[82] J. Hannon. Vitreous hemorrhages associated with sickle cell-hemoglobin C disease. , 1956, American journal of ophthalmology.
[83] L. Pauling,et al. Sickle cell anemia a molecular disease. , 1949, Science.
[84] J. Herrick,et al. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. 1910. , 1910, The Yale journal of biology and medicine.
[85] E. Sigler,et al. Temporal Macular Atrophy as a Predictor of Neovascularization in Sickle Cell Retinopathy. , 2016, Ophthalmic surgery, lasers & imaging retina.
[86] A. Scott,et al. Bevacizumab presurgical treatment for proliferative sickle-cell retinopathy-related retinal detachment. , 2013, Retinal cases & brief reports.
[87] N. B. Lerner,et al. Newborn sickle cell screening in a region of Western New York State. , 2009, The Journal of pediatrics.
[88] L. Jampol,et al. An update on techniques of photocoagulation treatment of proliferative sickle cell retinopathy , 1991, Eye.